Abstract:Vitamin D has an immunomodulatory effect on both innate and adaptive immune responses. Vitamin D has been reported to induce differentiation of monocytes into macrophages, inhibit maturation and differentiation of dendritic cells, and suppress adaptive immunity. Although there are some in vitro studies which showed that vitamin D suppressed Natural Killer (NK) cell activity and IFN‐γ secretion, little is known about the in vivo effect of vitamin D on NK cell functions. In this study, we investigated the in vivo effect of vitamin D on NK cell functions by measuring NK activity, cytokine secretion, activating receptor expression, and degranulation capacity in mice fed control or high‐fat diets containing different levels of vitamin D. Five week‐old C57BL/6 mice were divided into 6 groups by fat amount (10% or 45% kcal fat, CD or HFD) and vitamin D content (50, 1000, or 10000 IU/kg of diet, DD, DC, or DS), then fed diets for 12 weeks. NK cell activity was assessed using radioisotope 51 Cr release assay against YAC‐1 target cells. Splenocyte subpopulation was measured by flow cytometry (FACS) analysis. Intracellular expression of IFN‐γ by NK cell, CD4 T cell, and CD8 T cell and proportions of NK cells and CD8 T cells expressing NKG2D and CD107a were determined by FACS analysis upon stimulation of splenocytes with PMA (50 ng/mL)/ionomycin (0.5 μM) for 4 hours. NK activity was significantly higher in NDDS group than HFDDS group at effector to target (E:T) ratios of 100:1, 50:1, and 12.5:1. NDDS group showed significantly higher NK activity compared with NDDD and NDDC groups at E:T ratios of 100:1 and 50:1, whereas there was no significant difference in NK activity among HFDDD, HFDDC, and HFDDS groups. Splenic CD11b‐ NK cell population was significantly higher in NDDS group than HFDDS group, while splenic CD11b+ NK cell population tended to be higher in NDDS group compared with HFDDS group ( p =0.057). Percentage of splenic NKT cell was significantly higher in NDDS group than HFDDS group. There were significant differences in the splenic population of CD4 T cell, CD8 T cell, and B cell between ND and HFD groups ( p =0.042, p =0.001, p <0.001). Intracellular expression of IFN‐γ and surface expressions of NKG2D, and CD107a in NK cells were not affected by the different levels of vitamin D. However, there were significantly higher surface expressions of CD107a by CD8 T cells in NDDD group compared with NDDS group. In conclusion, vitamin D supplementation enhanced splenic NK activity in control mice, whereas this effect of vitamin D was not observed in high‐fat diet‐induced obese mice. Alternation in splenic NK cell population might have partially contributed to increased NK activity by vitamin D supplementation. Support or Funding Information Supported by the grant from the National Research Foundation (NRF) of Korea (NRF‐2015R1D1A1A01059679).

Dietary vitamin D 3 supplementation enhances splenic NK cell activity in healthy and diabetic male mice

Differential Effect of Vitamin D Supplementation on Natural Killer Cell Activity in Normal and Obese Mice

Natural Killer Cells Modulate Overt Autoimmunity to Homeostasis in Nonobese Diabetic Mice after Anti-CD3 F(ab′)2 Antibody Treatment through Secreting Transforming Growth Factor-β

Concentration of NK cells after β-glucan and vitamin D supplementation in patients with diabetic retinopathy

High Serum Vitamin D Concentrations, Induced via Diet, Trigger Immune and Intestinal Microbiota Alterations Leading to Type 1 Diabetes Protection in NOD Mice

Vitamin D supplementation could enhance the effectiveness of glibenclamide in treating type 2 diabetes by improving the function of pancreatic β-cells through the NF-κB pathway

Vitamin D supplementation induces CatG-mediated CD4+ T cell inactivation and restores pancreatic β-cell function in mice with type 1 diabetes

The Therapeutic Effect of Active Vitamin D Supplementation in Preventing the Progression of Diabetic Nephropathy in a Diabetic Mouse Model

Vitamin D3 alleviates cognitive impairment through regulating inflammatory stress in db/db mice

Vitamin D Alleviates Type 2 Diabetes Mellitus by Mitigating Oxidative Stress-Induced Pancreatic β-Cell Impairment

[Effect of vitamin D3 on mild cognitive impairment in type 2 diabetic mice and its possible mechanism]

The association between vitamin D and the progression of diabetic nephropathy: insights into potential mechanisms

Vitamin D Enhances Immune Effector Pathways of NK Cells Thus Providing a Mechanistic Explanation for the Increased Effectiveness of Therapeutic Monoclonal Antibodies

NK3-Like NK Cells Are Involved in Protective Effect of Polyinosinic-Polycytidylic Acid on Type 1 Diabetes in Nonobese Diabetic Mice

Vitamin D 3 improves glucose metabolism and attenuates inflammation in prediabetic human and mice

Vitamin D protects against high glucose-induced pancreatic 13-cell dysfunction via AMPK-NLRP3 inflammasome pathway

The effects of in vitro vitamin D treatment on glycolytic reprogramming of bone marrow-derived dendritic cells from Ldlr knock-out mouse

Vitamin D protects against high glucose-induced pancreatic β-cell dysfunction via AMPK-NLRP3 inflammasome pathway

Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer

Effects of Active Vitamin D on Insulin Resistance and Islet Β-Cell Function in Non-Diabetic Chronic Kidney Disease Patients: a Randomized Controlled Study

Induction of Active Tolerance and Involvement of Cd1d-Restricted Natural Killer T Cells in Anti-Cd3 F(Ab ')(2) Treatment-Reversed New-Onset Diabetes in Nonobese Diabetic Mice